Почетна › Метастатски карцином › Орегон
Клинички испитувања за Метастатски карцином во Орегон
29 студии за Метастатски карцином бараат учесници на локации во Орегон.
Градови во Орегон
Официјален текст на студијата (англиски)
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Willamette Valley Cancer Institute, Eugene
- Oregon Health and Science University, Portland
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07562152Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- и уште 1
Се регрутираФаза 2
Сите возрасти · Сите полови · Ажурирано 5.10.2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750A Study of ASP3082 in Adults With Advanced Solid Tumors
- Oregon Health and Science University, Portland
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT05382559A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 6, Portland
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07085091Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Oregon Health and Science University, Portland
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT06943755First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- Oregon Health & Science University, Portland
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05875168Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Oncology Associates of Oregon, P.C., Albany
- Kaiser Permanente Sunnyside Medical Center, Clackamas
- Oncology Associates of Oregon, P.C., Corvallis
- и уште 4
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07222800ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Oregon Health and Science University, Portland
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07007559A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06989437Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Northwest Cancer Specialists, P.C, Happy Valley
- Northwest Cancer Specialists, P.C., Portland
- Northwest Cancer Specialists, P.C, Tigard
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07222566A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
Се регрутираФаза 1
Возраст 18 и постари · Мажи · Ажурирано 24.9.2026 · NCT07543055A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- USO - Oncology Associates of Oregon, P. C., Eugene
- Providence Portland Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213804A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Good Samaritan Regional Medical Center, Corvallis
- Oncology Associates of Oregon, Eugene
- Oregon Health and Science University, Portland
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07174336Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Northwest Cancer Specialists, P.C., Portland
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07227415A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Oncology Associates of Oregon, Eugene
- Asante Rogue Regional Medical Center, Medford
- Providence Portland Medical Center, Portland
- и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Portland
Се регрутираФаза 2
Возраст од 18 до 130 · Сите полови · Ажурирано 18.8.2026 · NCT06792695FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05919264A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06242470A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Oregon Health & Science University, Portland
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Eugene
- Research Site, Portland
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 29.7.2026 · NCT07044336Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #121, Portland
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.7.2026 · NCT06974110Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
- OHSU Knight Cancer Institute, Portland
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 8.7.2026 · NCT06320405Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
Се регрутираФаза 2
Возраст 18 и постари · Мажи · Ажурирано 15.6.2026 · NCT05422911Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- OHSU Knight Cancer Institute, Portland
Се регрутираФаза 4
Возраст 18 и постари · Сите полови · Ажурирано 12.6.2026 · NCT07405086Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
- Providence Cancer Institute, Portland
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 6.3.2026 · NCT06171750Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Oregon Health & Science University Knight Cancer Institute, Portland
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 6.2.2026 · NCT06127407SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.